ÂÜÀòÂÒÂ×

Josh is co-founder and Managing Partner of Lux Capital, a venture capital firm that focuses on early-stage science and technology investments. Josh is a Director at Kallyope, Variant Bio, Gandeeva Therapeutics, and Strateos, and helped lead the firm’s investment in Resilience. Josh also serves as a Director at several other companies across the physical sciences and technology industries, including Shapeways, Varda, Kymeta, and Kurion. Before founding Lux Capital in 2000, Josh worked in investment banking at Salomon Smith Barney and in capital markets at Merril Lynch.